Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women's Health and Dermatology [Yahoo! Finance]
Hamilton Lane Incorporated - Class A (HLNE)
Last hamilton lane incorporated - class a earnings: 2/4 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.hamiltonlane.com/investors/overview/default.aspx
Company Research
Source: Yahoo! Finance
-- Acquisition Propels Cosette Into One Of The Leading Companies In Women's Health and Dermatology in the U.S. -- -- Highly Complementary Business Strengthens Cosette's Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach -- -- Utilizing Mayne Pharma's Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access -- BRIDGEWATER, N.J., February 20, 2025 BUSINESS WIRE )--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma's Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction. The transaction is expected to clo
Show less
Read more
Impact Snapshot
Event Time:
HLNE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HLNE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HLNE alerts
High impacting Hamilton Lane Incorporated - Class A news events
Weekly update
A roundup of the hottest topics
HLNE
News
- Hamilton Lane (NASDAQ:HLNE) had its price target raised by analysts at Keefe, Bruyette & Woods from $158.00 to $161.00. They now have an "outperform" rating on the stock.MarketBeat
- Anchorage Digital Acquires Securitize Platform in Major Crypto Wealth Management Consolidation [Yahoo! Finance]Yahoo! Finance
- Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of CIPRO® HC (ciprofloxacin 0.2% HCl and hydrocortisone 1% otic suspension), with 180 days Competitive Generic Therapy (CGT) exclusivityBusiness Wire
- Slate Asset Management and Hamilton Lane Acquire Majority Stake in Cold-Link Logistics, a Leading North American Cold Storage PlatformBusiness Wire
- Hamilton Lane (NASDAQ:HLNE) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.MarketBeat
HLNE
Earnings
- 11/4/25 - Beat
HLNE
Sec Filings
- 11/10/25 - Form 4
- 11/4/25 - Form 10-Q
- 11/4/25 - Form 8-K
- HLNE's page on the SEC website